2015-001221-16
A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic Episode
Janssen Cilag N.V./S.A·EU Clinical Trials Register
Study focus
- Disease/Condition
- Schizophrenia
Sponsor & location
- Primary sponsor
- Janssen Cilag N.V./S.A
- Funder
- Janssen EMEA Medical Affairs
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
- Participants requiring treatment with mood stabilizers or antidepressants at study entry
ICD-10 classifications
SchizophreniaSimple schizophreniaSchizophrenia, unspecifiedOther schizophreniaParanoid schizophrenia
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2015-001221-16
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2015-001221-16 through Pure Global AI's free database. This phase not specified trial is sponsored by Janssen Cilag N.V./S.A and is currently status unknown. The study focuses on Schizophrenia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.